All Things Urticaria
Science & Technology News
Catch up on ’All Things Urticaria’ in this podcast series developed by GA²LEN UCARE in collaboration with Medthority. Professor Marcus Maurer, Professor of Dermatology and Allergy at Charité – Universitätsmedizin Berlin, is joined by colleagues for in-depth discussions on the latest research and opinion on the pathogenesis and treatment of urticaria. Medthority received educational funding from the sponsor to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated content. The opinions in this podcast are of the invited faculty, for informational purposes only, and should not be taken as medical advice. Please consult your regional guidelines for clinical practice recommendations in your area. For updates on ’All Things Urticaria’, sign up on Medthority. For more on UCARE/ACARE activities, visit the UCARE and ACARE websites, UCARE 4U, UDAY, CRUSE Control App, and CURE Registry. Episodes 1 – 61: This content has been developed independently of the sponsor, Novartis Pharma AG. Episode 31 and 33: This content has been in collaboration with J. Uriach y Compañía S.A.
Location:
United States
Description:
Catch up on ’All Things Urticaria’ in this podcast series developed by GA²LEN UCARE in collaboration with Medthority. Professor Marcus Maurer, Professor of Dermatology and Allergy at Charité – Universitätsmedizin Berlin, is joined by colleagues for in-depth discussions on the latest research and opinion on the pathogenesis and treatment of urticaria. Medthority received educational funding from the sponsor to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated content. The opinions in this podcast are of the invited faculty, for informational purposes only, and should not be taken as medical advice. Please consult your regional guidelines for clinical practice recommendations in your area. For updates on ’All Things Urticaria’, sign up on Medthority. For more on UCARE/ACARE activities, visit the UCARE and ACARE websites, UCARE 4U, UDAY, CRUSE Control App, and CURE Registry. Episodes 1 – 61: This content has been developed independently of the sponsor, Novartis Pharma AG. Episode 31 and 33: This content has been in collaboration with J. Uriach y Compañía S.A.
Language:
English
Episode 87 - Clinical trials in urticaria
Duration:00:22:27
Episode 86 - CU: A Hong Kong perspective
Duration:00:25:40
Episode 85 - How can we educate dermatologists on urticaria?
Duration:00:23:19
Episode 84 - Does country make a difference?
Duration:00:27:07
Episode 83 - Chronic Angioedema Registry (CARE)
Duration:00:29:20
Episode 82 - Managing autoimmune CSU
Duration:00:26:13
Episode 81 - UCARE Conference 2023
Duration:00:23:37
Episode 80 - Living with CSU: The patient’s voice
Duration:00:27:44
Episode 79 - Apps, refugees, and the future of digital healthcare
Duration:00:16:13
Episode 78 - What is cold urticaria?
Duration:00:23:46
Episode 77 - Antihistamines and urticaria
Duration:00:23:00
Episode 76 - Clinical nurse specialists: Leading collaborative care
Duration:00:19:09
Episode 75 - Urticaria in a veterinary setting
Duration:00:16:36
Episode 74 - Non-steroidal anti-inflammatory drugs in CSU
Duration:00:23:42
Episode 73 - Urticaria and stress
Duration:00:22:55
Episode 72 - IL-9, IL-10 and CSU pathogenesis
Duration:00:18:39
Episode 71 - The patient perspective
Duration:00:24:30
Episode 70 - Urticaria management in resource-poor settings
Duration:00:20:39
Episode 69 - The burdens of angioedema
Duration:00:24:39
Episode 68 - Angioedema and CSU
Duration:00:23:06